drugset / Trial / NCT00728611

Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee

NCT00728611

Phase 2/3 Completed 60 enrolled Meir Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

to evaluate the influence of PRGF treatment on patient suffering from OA knee

Timeline

Start
2008-01
Primary completion
2009-02
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hyaluronic Acid Other / unclassified 20 mg
Subject PRGFs Protein / enzyme biologic 6 mg Other

Indications